ACCESSION: MSBNK-SMB_Measured-HSA001P0172010
RECORD_TITLE: Annotated; Gabapentin; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.04 (Averaged 2025.02.14, Processed 2025.02.14, Annotated 2025.02.21, Curated 2025.03.04)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 29
COMMENT: RAW_SPEC {'1_posi_3367': {'bp': 186878.0, 'sum': 1190877.0}, '5_posi_3327': {'bp': 94891.0, 'sum': 825050.0}, '12_posi_3388': {'bp': 142512.0, 'sum': 1038078.0}, '17_posi_3452': {'bp': 144020.0, 'sum': 1078650.0}, '6_posi_3368': {'bp': 152474.0, 'sum': 965644.0}, '8_posi_3407': {'bp': 167926.0, 'sum': 1210256.0}, '16_posi_3350': {'bp': 79788.0, 'sum': 695135.0}, '16_posi_3409': {'bp': 137149.0, 'sum': 976609.0}, '4_posi_3347': {'bp': 153480.0, 'sum': 1073357.0}, '10_posi_3388': {'bp': 122802.0, 'sum': 1028532.0}, '15_posi_3408': {'bp': 142254.0, 'sum': 959691.0}, '14_posi_3368': {'bp': 100509.0, 'sum': 809951.0}, '13_posi_3407': {'bp': 139363.0, 'sum': 951171.0}, '15_posi_3474': {'bp': 147438.0, 'sum': 881465.0}, '14_posi_3431': {'bp': 169040.0, 'sum': 1180700.0}, '19_posi_3515': {'bp': 139126.0, 'sum': 944517.0}, '11_posi_3408': {'bp': 148219.0, 'sum': 956027.0}, '4_posi_3409': {'bp': 172843.0, 'sum': 1094556.0}, '3_posi_3388': {'bp': 174242.0, 'sum': 1197106.0}, '7_posi_3368': {'bp': 142712.0, 'sum': 969523.0}, '2_posi_3366': {'bp': 173186.0, 'sum': 1159317.0}, '9_posi_3430': {'bp': 169976.0, 'sum': 1077023.0}, '9_posi_3367': {'bp': 120884.0, 'sum': 1020618.0}, '18_posi_3413': {'bp': 102395.0, 'sum': 731173.0}, '8_posi_3348': {'bp': 84556.0, 'sum': 747781.0}, '17_posi_3372': {'bp': 78322.0, 'sum': 622720.0}, '18_posi_3477': {'bp': 151601.0, 'sum': 898465.0}, '5_posi_3389': {'bp': 176374.0, 'sum': 1244923.0}, '19_posi_3452': {'bp': 104184.0, 'sum': 812796.0}}
COMMENT: RETENTION_TIME_STDEV 0.088
COMMENT: PRECURSOR_M/Z_RAW 172.132815
COMMENT: PRECURSOR_M/Z_STDEV 0.000038
COMMENT: PRECURSOR_IN_MS1 mz 172.133141; int 56.916; delta(ppm) 1.219651
COMMENT: PROPOSED_CHARGE_STATE +1; mz 173.136509; int 4.818; cor 0.852
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.368; C9H17NO2; [M+H]+; delta(ppm) -0.368150
COMMENT: PROPOSED_MF MS-FINDER 3.476; C9H17NO2; [M+H]+; delta(ppm) -0.367306
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.439; C9H17NO2; [M+H]+; delta(ppm) -0.367306
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C9H17NO2; [M+H]+; delta(ppm) -0.367306
COMMENT: PROPOSED_MF SIRIUS6_Sirius 38.608; C9H17NO2; [M+H]+; delta(ppm) -0.367306
COMMENT: PROPOSED_MF SIRIUS6_Sirius 19.247; C7H15N4O; [M+H]+; delta(ppm) 7.432895
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H17NO2; [M+H]+; delta(ppm) -0.367306
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 2.000; UGJMXCAKCUNAIE-UHFFFAOYSA-N; C9H17NO2; Spectral Match to Gabapentin from NIST14
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.754; UGJMXCAKCUNAIE-UHFFFAOYSA-N; [M+H]+; NCC1(CC(O)=O)CCCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.636; XGRSAFKZAGGXJV-UHFFFAOYSA-N; [M+H]+; C1CCC(CC1)C(CC(=O)O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.628; XEZIHBDQTJPSAA-UHFFFAOYSA-N; [M+H]+; C1CCC(CC1)(CCC(=O)O)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.615; VMTBKRPFIUIKPK-UHFFFAOYNA-N; [M+H]+; NCC1CCCCC1CC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.566; JCJZYYMSYSBZSL-UHFFFAOYSA-N; [M+H]+; O=C(NC1(C)CCCCC1O)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.050; UGJMXCAKCUNAIE-UHFFFAOYSA-N; [M+H]+; Gabapentin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.745; ORQXBVXKBGUSBA-QMMMGPOBSA-N; [M+H]+; Beta-Cyclohexyl-Alanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.635; KYKBHRVKONYRBO-AATRIKPKSA-N; [M+H]+; (E)-3-hydroxy-2,4-dimethylhept-4-enamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.598; VMTBKRPFIUIKPK-UHFFFAOYNA-N; [M+H]+; 2-[2-(aminomethyl)cyclohexyl]acetic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.589; NDZOXZDXQXPVMM-UHFFFAOYSA-N; [M+H]+; 2-azaniumylnon-5-enoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.546; XEZIHBDQTJPSAA-UHFFFAOYSA-N; [M+H]+; 3-(1-aminocyclohexyl)propanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.530; FBJHAMGGVKCNEB-UHFFFAOYSA-N; [M+H]+; 3-aminonon-5-enoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.529; XGRSAFKZAGGXJV-UHFFFAOYSA-N; [M+H]+; 3-amino-3-cyclohexylpropanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.402; WPLPJEWZNOILAV-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropyl)pyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.342; NADRXDBGSGCPBM-UHFFFAOYSA-N; [M+H]+; [1-(aminomethyl)cyclohexyl] acetate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.243; JCJZYYMSYSBZSL-UHFFFAOYSA-N; [M+H]+; N-(2-hydroxy-1-methylcyclohexyl)acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.242; LBMYKRXWOHTRIK-UHFFFAOYNA-N; [M+H]+; Cyclobutanepropanoic acid, a-amino-, ethyl ester
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.227; UDSGFNPTFXGSAU-UHFFFAOYSA-N; [M+H]+; N-(hydroxymethyl)-N,1,2,2-tetramethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.123; KVOOZKISXYTWCJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-(morpholin-4-yl)propanal
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.072; OVQSLAXVKJVHJO-UHFFFAOYSA-N; [M+H]+; (1-methylpiperidin-4-yl) propanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.043; ZICBNHLULHJETL-UHFFFAOYSA-N; [M+H]+; ethyl 1-methylpiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.042; KMEUSKGEUADGET-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.029; VFJJNMLPRDRTCO-SVGMAFHSNA-N; [M+H]+; UNPD160363
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; FBJHAMGGVKCNEB-UHFFFAOYSA-N; [M+H]+; 3-aminonon-5-enoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; UGJMXCAKCUNAIE-UHFFFAOYSA-N; [M+H]+; Gabapentin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; VMTBKRPFIUIKPK-UHFFFAOYNA-N; [M+H]+; 2-[2-(aminomethyl)cyclohexyl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; XEZIHBDQTJPSAA-UHFFFAOYSA-N; [M+H]+; 3-(1-aminocyclohexyl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.979; XGRSAFKZAGGXJV-UHFFFAOYSA-N; [M+H]+; 3-amino-3-cyclohexylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.968; NDZOXZDXQXPVMM-UHFFFAOYSA-N; [M+H]+; 2-azaniumylnon-5-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.947; ORQXBVXKBGUSBA-QMMMGPOBSA-N; [M+H]+; Beta-Cyclohexyl-Alanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.892; WPLPJEWZNOILAV-UHFFFAOYSA-N; [M+H]+; 4-(2-methylpropyl)pyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.850; KYKBHRVKONYRBO-AATRIKPKSA-N; [M+H]+; (E)-3-hydroxy-2,4-dimethylhept-4-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.786; NADRXDBGSGCPBM-UHFFFAOYSA-N; [M+H]+; [1-(aminomethyl)cyclohexyl] acetate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.762; LBMYKRXWOHTRIK-UHFFFAOYNA-N; [M+H]+; Cyclobutanepropanoic acid, a-amino-, ethyl ester
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.709; KMEUSKGEUADGET-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.624; JCJZYYMSYSBZSL-UHFFFAOYSA-N; [M+H]+; N-(2-hydroxy-1-methylcyclohexyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.605; UDSGFNPTFXGSAU-UHFFFAOYSA-N; [M+H]+; N-(hydroxymethyl)-N,1,2,2-tetramethylcyclopropane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.445; VFJJNMLPRDRTCO-SVGMAFHSNA-N; [M+H]+; UNPD160363
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.445; ZICBNHLULHJETL-UHFFFAOYSA-N; [M+H]+; ethyl 1-methylpiperidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.442; KVOOZKISXYTWCJ-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-(morpholin-4-yl)propanal
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.320; OVQSLAXVKJVHJO-UHFFFAOYSA-N; [M+H]+; (1-methylpiperidin-4-yl) propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.976; UGJMXCAKCUNAIE-UHFFFAOYSA-N; [M+H]+; 2-[1-(aminomethyl)cyclohexyl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.585; QHVBLSNVXDSMEB-UHFFFAOYSA-N; [M+H]+; 2-(diethylamino)ethyl prop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.541; ORQXBVXKBGUSBA-UHFFFAOYSA-N; [M+H]+; 2-amino-3-cyclohexylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; QRVJLPJGOXCAQV-UHFFFAOYSA-N; [M+H]+; [2-[amino(cyclopropyl)methyl]oxolan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.121; XEZIHBDQTJPSAA-UHFFFAOYSA-N; [M+H]+; 3-(1-aminocyclohexyl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.119; XGRSAFKZAGGXJV-QMMMGPOBSA-N; [M+H]+; (3S)-3-amino-3-cyclohexylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; UMFZYZDSLPTDRA-UHFFFAOYSA-N; [M+H]+; 1-(2-aminoethyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.118; YLRYOSMRXZIAHT-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-3-cyclopentylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.113; RNDBJXMOBPVFAS-JGVFFNPUSA-N; [M+H]+; (1S,2R)-2-aminocyclooctane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; PJSQECUPWDUIBT-UHFFFAOYSA-N; [M+H]+; 1-aminocyclooctane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.101; NOLACALASLWZMH-UHFFFAOYSA-N; [M+H]+; [2-(aminomethyl)-6-oxaspiro[2.5]octan-2-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.101; YGHHMEXCWAPDKY-UHFFFAOYSA-N; [M+H]+; 3-[1-(aminomethyl)cyclopropyl]oxan-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.088; PSGUGXRSYIUWDV-UHFFFAOYSA-N; [M+H]+; [4-(aminomethyl)-2-oxabicyclo[2.2.2]octan-1-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; GMLQOIMQMLOTNY-UHFFFAOYSA-N; [M+H]+; 2-amino-2-cycloheptylacetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; JXKLPTPNYNKUDP-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(3-methylcyclohexyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; ZKVWUXSBUSFWDO-UHFFFAOYSA-N; [M+H]+; 2-amino-2-(1-methylcyclohexyl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; IEFQYFFTBQOEBR-UHFFFAOYSA-N; [M+H]+; 1-amino-4,4-dimethylcyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; NNLUUBZIUUDZLR-UHFFFAOYSA-N; [M+H]+; 1-amino-3,3-dimethylcyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.032; PEFJXLRRICMJFX-UHFFFAOYSA-N; [M+H]+; 2-propylpiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.031; QLGHIRUNPFAEHQ-UHFFFAOYSA-N; [M+H]+; 2-morpholin-3-ylcyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.027; AEXUBVPGANVPIF-UHFFFAOYSA-N; [M+H]+; 8-oxa-2-azaspiro[4.5]decan-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.021; OILYAPVNRYNPRT-UHFFFAOYSA-N; [M+H]+; 2-[4-(aminomethyl)cyclohexyl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.020; HFTGWHYUKOUNOV-UHFFFAOYSA-N; [M+H]+; 4-(2-aminoethyl)cyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; RGLAGNYFUKLAJX-UHFFFAOYSA-N; [M+H]+; (1-ethylcyclohexyl) carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.015; VKKXOOQNBTVWAT-UHFFFAOYSA-N; [M+H]+; 4-piperidin-2-ylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; CCLXSEBEYQHZPL-UHFFFAOYSA-N; [M+H]+; 2-(2,2-dimethylpiperidin-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; YSULVJBVYBBLJI-JGVFFNPUSA-N; [M+H]+; (8R,9S)-6-azaspiro[4.5]decane-8,9-diol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; KADOSLYSZOBSFM-YUMQZZPRSA-N; [M+H]+; 2-[(3R,4S)-3-ethylpiperidin-4-yl]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; BIISFEDNPFAAKS-UHFFFAOYSA-N; [M+H]+; 8-oxa-2-azaspiro[4.5]decan-4-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.003; JXAVEFFTHCFRPE-UHFFFAOYSA-N; [M+H]+; 8-oxa-1-azaspiro[4.5]decan-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.000; PKKMWSSDRQBNKG-UHFFFAOYSA-N; [M+H]+; 3-pyrrolidin-2-yloxan-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.988; AYHNBGJVKFAWNB-UHFFFAOYSA-N; [M+H]+; 1-amino-3-tert-butylcyclobutane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; KMEUSKGEUADGET-UHFFFAOYSA-N; [M+H]+; 1-hydroxy-2,2,6,6-tetramethylpiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.948; JDKQQRVWDJKDOC-UHFFFAOYSA-N; [M+H]+; 1,4-dioxaspiro[5.5]undecan-9-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.939; UUSVVDQFPGXFTQ-QMMMGPOBSA-N; [M+H]+; methyl (2S)-2-amino-2-cyclohexylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; QXRALRQVSKYBDB-UHFFFAOYSA-N; [M+H]+; methyl 1-amino-4-methylcyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; GPZHQNYVDQMZDP-UHFFFAOYSA-N; [M+H]+; methyl 1-aminocycloheptane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; RLMHBOGYHKMLFN-UHFFFAOYSA-N; [M+H]+; methyl 2-(1-aminocyclohexyl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; ACVKFIYOVXQWEM-UHFFFAOYSA-N; [M+H]+; methyl 1-(aminomethyl)cyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; RTNWEIURRWNLEA-UHFFFAOYSA-N; [M+H]+; 8-methyl-1,4-dioxaspiro[4.5]decan-8-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.935; NLTUVNXVLWWVMX-SFYZADRCSA-N; [M+H]+; methyl (1R,2S)-2-aminocycloheptane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; NBWDADGCWZGJAF-UHFFFAOYSA-N; [M+H]+; methyl 4-aminocycloheptane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; PKWOIHUJZDEWFL-UHFFFAOYSA-N; [M+H]+; methyl 2-[1-(aminomethyl)cyclopentyl]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; ZBULWEPSBNFXMB-UHFFFAOYSA-N; [M+H]+; methyl 2-(3-aminocyclohexyl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; DBVNXOZIQQNAJE-UHFFFAOYSA-N; [M+H]+; methyl 3-amino-3-cyclopentylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; ZDEKKLLOCHUNDD-UHFFFAOYSA-N; [M+H]+; methyl 2-amino-2-methylcyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; SMXBVUPVPLXXMS-SSDOTTSWSA-N; [M+H]+; methyl (3R)-3-amino-3-cyclopropyl-2,2-dimethylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; OEBYRQFXIBUGSR-UHFFFAOYSA-N; [M+H]+; 1,4-dioxaspiro[4.5]decan-8-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; PJWRZNHJMHNNFJ-UHFFFAOYSA-N; [M+H]+; 1,9-dioxaspiro[5.5]undecan-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; VXTSEPDCQOGHJA-UHFFFAOYSA-N; [M+H]+; 3-ethoxy-5-oxaspiro[3.4]octan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.922; NXLRGDXXDFJRDG-UHFFFAOYSA-N; [M+H]+; 1,9-dioxaspiro[5.5]undecan-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.918; KAGAVYWDCRKZEB-UHFFFAOYSA-N; [M+H]+; methyl 2-(3-amino-2,2-dimethylcyclobutyl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; MSTPNVITZIFFEK-UHFFFAOYSA-N; [M+H]+; 4-piperidin-4-ylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.913; JVKWPAGLRNGSIO-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-piperidin-4-ylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; MVFMEHOBPSVMRI-UHFFFAOYSA-N; [M+H]+; 2-methyl-3-piperidin-4-ylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; KUAFMPWKUNNUEC-UHFFFAOYSA-N; [M+H]+; ethyl 1-aminocyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; VODUKXHGDCJEOZ-SFYZADRCSA-N; [M+H]+; ethyl (1R,2S)-2-aminocyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; VALZPPHHDRBGHU-SFYZADRCSA-N; [M+H]+; ethyl (1R,3S)-3-aminocyclohexane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; LBMYKRXWOHTRIK-UHFFFAOYSA-N; [M+H]+; ethyl 2-amino-3-cyclobutylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.903; AKUKXMNTGXTIAH-UHFFFAOYSA-N; [M+H]+; ethyl 1-(aminomethyl)cyclopentane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; FQYGSNXTOJSDAQ-UHFFFAOYSA-N; [M+H]+; ethyl 2-(1-aminocyclopentyl)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.902; QIHMFSRVNXGXQC-QMMMGPOBSA-N; [M+H]+; ethyl (2S)-2-amino-2-cyclopentylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; KCUQSNWLGMSEOQ-ZETCQYMHSA-N; [M+H]+; tert-butyl (2S)-2-amino-2-cyclopropylacetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.892; FHXNYYFOSMSGPE-UHFFFAOYSA-N; [M+H]+; 1,4-dioxaspiro[4.5]decan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.886; CGUJSNKYHNQLMB-UHFFFAOYSA-N; [M+H]+; tert-butyl 1-aminocyclobutane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; BGAVZPPPWLEAKZ-UHFFFAOYSA-N; [M+H]+; 4-piperidin-1-ylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; ADGJZVKOKVENDN-UHFFFAOYSA-N; [M+H]+; N-(butoxymethyl)-2-methylprop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.866; WWJCRUKUIQRCGP-UHFFFAOYSA-N; [M+H]+; 3-(dimethylamino)propyl 2-methylprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; KNRNVMUJMBOCRF-UHFFFAOYSA-N; [M+H]+; tert-butyl 3-aminocyclobutane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.803; VKMKOHKFVXVSFK-UHFFFAOYSA-N; [M+H]+; tert-butyl 1-(aminomethyl)cyclopropane-1-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; RQYGHUVAVDHACS-UHFFFAOYSA-N; [M+H]+; N-cyclopentyl-3-methoxypropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.787; MYZYATBOEKPPPB-UHFFFAOYSA-N; [M+H]+; 3-(4-hydroxy-4-methylpentan-2-yl)oxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; DCYUJGGJVYIWAG-UHFFFAOYSA-N; [M+H]+; propan-2-yl piperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.779; TWYISXLZCIVDDW-UHFFFAOYSA-N; [M+H]+; 2-methyl-N-(2-methylpropoxymethyl)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.775; FPVDZMNFQWOQNJ-DTWKUNHWSA-N; [M+H]+; [(4R,8aS)-4-methyl-1,3,6,7,8,8a-hexahydropyrrolo[2,1-c][1,4]oxazin-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; UZEQMPFHOHHHOB-UHFFFAOYSA-N; [M+H]+; methyl 6-ethylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; VUYOLFCBKTYCAL-UHFFFAOYSA-N; [M+H]+; methyl 4-ethylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; AQMVNIAPISYBIJ-UHFFFAOYSA-N; [M+H]+; methyl 3-ethylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.765; GNAGNRYPVFRSKN-UHFFFAOYSA-N; [M+H]+; methyl 2-propylpyrrolidine-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; JMCANWXKEVZZPJ-UHFFFAOYSA-N; [M+H]+; 3,8-dioxa-11-azaspiro[5.6]dodecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; IBIZDOPRLFKJHM-UHFFFAOYSA-N; [M+H]+; 3-(oxan-4-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; YQPVVNOZTVENQF-UHFFFAOYSA-N; [M+H]+; 3-(oxolan-3-ylmethyl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; ASWOTAGCRDJKOF-UHFFFAOYSA-N; [M+H]+; 3,10-dioxa-7-azaspiro[5.6]dodecane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.760; MQQGENHQDYYHHM-UHFFFAOYSA-N; [M+H]+; 4-(1,4-dioxan-2-yl)piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.751; QDOQCOOUTPQMKW-UHFFFAOYSA-N; [M+H]+; 1-propan-2-ylpiperidine-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.750; OSUCMSQHXIGGKX-UHFFFAOYSA-N; [M+H]+; 1-(hydroxymethyl)-N-methylcyclohexane-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.749; FGTFCEJPMHOBDS-UHFFFAOYSA-N; [M+H]+; methyl 3-piperidin-4-ylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; OXWOWPPWADRGGB-UHFFFAOYSA-N; [M+H]+; methyl 3,3-dimethylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; ULNFQKRYRMPKOP-UHFFFAOYSA-N; [M+H]+; 2-(2-oxa-7-azaspiro[3.5]nonan-7-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; VJCAJSGDZGKOBU-UHFFFAOYSA-N; [M+H]+; methyl 3-piperidin-3-ylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; ZYWHDXBOSGFUFC-UHFFFAOYSA-N; [M+H]+; 3-(1-methylpiperidin-2-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; FVKWNSIHIYFCMH-UHFFFAOYSA-N; [M+H]+; 3-(1-methylpiperidin-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; BYPJUZDWADRQOF-UHFFFAOYSA-N; [M+H]+; 2-(1-methylazepan-4-yl)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; AMRCSFBRIBGWOS-UHFFFAOYSA-N; [M+H]+; methyl 2-methyl-2-pyrrolidin-2-ylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; SCSANXWNALCTOF-UHFFFAOYSA-N; [M+H]+; methyl 2,6-dimethylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; OHRJLBSZEZWTNR-UHFFFAOYSA-N; [M+H]+; methyl 2,2-dimethylpiperidine-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.746; WWEMGEIEZFUSEK-UHFFFAOYSA-N; [M+H]+; methyl azocane-2-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.746; MOSQXQJFELRIMD-UHFFFAOYSA-N; [M+H]+; methyl 2,6-dimethylpiperidine-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.746; PKCYTZWZCRORJV-UHFFFAOYSA-N; [M+H]+; methyl 2-methylazepane-2-carboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -23.787; UGJMXCAKCUNAIE; [M+H]+; Aclonium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -67.915; VMTBKRPFIUIKPK; [M+H]+; Pharmakon1600-01505805
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -118.758; FBJHAMGGVKCNEB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -135.545; MSTPNVITZIFFEK; [M+H]+; 4-Piperidinebutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.688; ACVKFIYOVXQWEM; [M+H]+; Methyl 1-(aminomethyl)cyclohexanecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -140.514; ORQXBVXKBGUSBA; [M+H]+; Maybridge4_003592
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.592; JXKLPTPNYNKUDP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -162.685; FQMUKYUCRWDMQY; [M+H]+; 5(S)-Amino-7-methyl-3(E)-octenoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -163.963; BGAVZPPPWLEAKZ; [M+H]+; NCIStruc1_000333
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.727; RLMHBOGYHKMLFN; [M+H]+; methyl (1-aminocyclohexyl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -175.637; PJSQECUPWDUIBT; [M+H]+; (1-carboxycyclooctyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.526; GGPGBWZFDWFGBZ; [M+H]+; 2-oxononanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.456; ATFRXUJCSMOJPH; [M+H]+; 3-Cyclohexylaminopropionic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.855; MXHJLIPWRZOKKY; [M+H]+; 2-(3-ethylpiperidin-1-yl)acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.590; RJFIWCWTENIBKC; [M+H]+; ACMC-20aint
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.265; IHSUFLCKRIHFGY; [M+H]+; ACMC-20aiuo
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -201.582; WASRJUXSLHUONH; [M+H]+; Oprea1_557108
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -204.651; NDZOXZDXQXPVMM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -211.338; LBMYKRXWOHTRIK; [M+H]+; ethyl 2-azanyl-3-cyclobutyl-propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.290; MXRVDXQFAGJLAO; [M+H]+; 4-(1-methylpyrrolidin-1-ium-1-yl)butanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -222.802; OSUBSXBLNSDLKI; [M+H]+; 3-(2-butoxyethoxy)propanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.527; MMVXPFGLJQHIQR; [M+H]+; 4-Nitro-3-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.651; MYZYATBOEKPPPB; [M+H]+; 4-Cyanoethoxy-2-methyl-2-pentanol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.412; CSXIWVFKBYEYCP; [M+H]+; 3-Nitro-2-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.736; KNRNVMUJMBOCRF; [M+H]+; tert-butyl 3-aminocyclobutanecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.989; OSUCMSQHXIGGKX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.025; LXZHLNWWDDNIOJ; [M+H]+; ethyl 2-piperidylacetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.969; BVAUMRCGVHUWOZ; [M+H]+; DL-Cyclohexylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -242.996; RATQMHARHJEZIR; [M+H]+; 2-Nitro-2-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.705; YUWSENDKBFKEMK; [M+H]+; Methyl pyrrolidine-1-butyrate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.746; DXAUPHVMJXKRRE; [M+H]+; N,N-Bis(2,3-epoxypropyl)isopropylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -253.729; RGLAGNYFUKLAJX; [M+H]+; 1-Ethylcyclohexyl carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.309; KCQRMTZJRMLATE; [M+H]+; 1-(1-Hydroxycyclohexyl)ethanone O-methyloxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -263.030; GNUZJPUUUCAMNF; [M+H]+; methyl 2-(azepan-1-yl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.533; MVPICKVDHDWCJQ; [M+H]+; Ethyl 1-pyrrolidinepropionate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.583; QTNRZJBKFAASKI; [M+H]+; 5-Nitro-4-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -267.661; VDRYTURBQHVHLA; [M+H]+; Levulinamide, N,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -268.858; QFWBXLYVHOMANN; [M+H]+; 1-(3-methoxypropyl)piperidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.486; PVFHNKAOCOVFKO; [M+H]+; 2-Azepan-1-yl-propionic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.114; DWTJGAYPBZHTDX; [M+H]+; 4-Nitro-4-nonene
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -280.382; KYKBHRVKONYRBO; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -281.737; JWXOOQCMGJBSML; [M+H]+; N-Methyl ethyl isonipecotate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -285.247; ZICBNHLULHJETL; [M+H]+; Ethyl 1-Methylpipecolate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -286.284; KVOOZKISXYTWCJ; [M+H]+; Ambcb4004287
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.019; QTALNDLQMOUACM; [M+H]+; Hexamethyleneurethane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -291.934; RKCYYKCHYZJRKP; [M+H]+; 4-(Diethylamino)-2-methyl-2-butenoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.316; OVQSLAXVKJVHJO; [M+H]+; N-Methylpiperidyl propionate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.204; XWAHLXHVEMYNMY; [M+H]+; ACMC-20dmhi
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -300.190; CKYVYVAZNCMKAO; [M+H]+; methyl 2-methyl-3-pyrrolidin-1-ylpropanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -302.178; CUDOPASYFARLIF; [M+H]+; (-)-1-Ethyl-L-proline Ethyl Ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.859; ZAVUHLXZFYNAMG; [M+H]+; N-Cyclohexaneurethane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.114; RLLHZFFYWQCWAP; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -312.266; QHVBLSNVXDSMEB; [M+H]+; Ageflex FA-2
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -316.428; AMZJRURRCKEEGQ; [M+H]+; Acetylpyrrolidinecholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.699; VFJJNMLPRDRTCO; [M+H]+; Ethyl 1-methylnipecotate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.357; KMEUSKGEUADGET; [M+H]+; Tempone-H
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -322.175; XJJBXZIKXFOMLP; [M+H]+; tert-butyl prolinate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -324.586; ZGEDPDWIZTXRJQ; [M+H]+; butan-2-yl 3-(aziridin-1-yl)propanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -326.342; HDCWURBOMBHSRI; [M+H]+; (1-methylazepan-3-yl) acetate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -332.544; WWJCRUKUIQRCGP; [M+H]+; 3-(Dimethylamino)propyl methacrylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -340.004; LPQZERIRKRYGGM; [M+H]+; ACMC-20aivt
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -351.968; XKOQIVSZENKHPJ; [M+H]+; Muscarone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -352.200; UOISBTHHJANVEM; [M+H]+; 1-(dimethylamino)propan-2-yl methacrylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -355.370; ADGJZVKOKVENDN; [M+H]+; N-(Butoxymethyl)methacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -356.837; JCJZYYMSYSBZSL; [M+H]+; N-[(1R,2S)-2-hydroxy-1-methylcyclohexyl]acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -360.917; DYEAYLYVJSBXII; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -361.074; BGCBKTVIXRMRQY; [M+H]+; 1,1-Dimethyl-3-acetoxypiperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -362.031; USFMMZYROHDWPJ; [M+H]+; Methacrylylcholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -365.591; YWSXTMBDIBZHBB; [M+H]+; Carbamic acid, 3-butenyl-, 1,1-dimethylethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -365.960; SCCPQPQIOJNZIE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -366.314; MDQZKNJHOMOCIW; [M+H]+; trimethyl(2-prop-2-enoyloxypropyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -372.838; PSPMGMPBVJFPLL; [M+H]+; 2-Acetoxycyclobutyltrimethylammonium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -374.944; TWYISXLZCIVDDW; [M+H]+; n-(isobutoxymethyl)-2-methylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -410.998; TXJWOPUIAVNZQP; [M+H]+; trimethyl(1-prop-2-enoyloxypropan-2-yl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.601; UGJMXCAKCUNAIE; [M+H]+; Aclonium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -24.285; UGJMXCAKCUNAIE; [M+H]+; 2-[1-(aminomethyl)cyclohexyl]acetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -57.095; VMTBKRPFIUIKPK; [M+H]+; 2-[2-(azaniumylmethyl)cyclohexyl]acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.418; XGRSAFKZAGGXJV; [M+H]+; 3-Amino-3-cyclohexylpropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -135.281; XEZIHBDQTJPSAA; [M+H]+; 3-(1-Aminocyclohexyl)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -159.362; FBJHAMGGVKCNEB; [M+H]+; 3-aminonon-5-enoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -182.559; RLMHBOGYHKMLFN; [M+H]+; Methyl 2-(1-aminocyclohexyl)acetate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -183.063; WPLPJEWZNOILAV; [M+H]+; (3S,4S)-4-Isobutylpyrrolidine-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.605; MSTPNVITZIFFEK; [M+H]+; 4-Piperidin-1-ium-4-ylbutanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -192.647; ORQXBVXKBGUSBA; [M+H]+; 2-amino-3-cyclohexylpropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -198.457; ACVKFIYOVXQWEM; [M+H]+; Methyl 1-(aminomethyl)cyclohexanecarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.940; UGJMXCAKCUNAIE; [M+H]+; 2-[1-(aminomethyl)cyclohexyl]acetic acid
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Gabapentin, UGJMXCAKCUNAIE-UHFFFAOYSA-N; Matching to 2 measured spectra (Dot product > 0.7); Proposed by SIRIUS6_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0005015;
CH$NAME: Gabapentin
CH$NAME: 2-[1-(aminomethyl)cyclohexyl]acetic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C9H17NO2
CH$EXACT_MASS: 171.125929
CH$SMILES: C1CCC(CC1)(CC(=O)O)CN
CH$IUPAC: InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)
CH$LINK: CHEBI CHEBI:42797
CH$LINK: HMDB HMDB0005015
CH$LINK: INCHIKEY UGJMXCAKCUNAIE-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:3446
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 6.813
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 172.133142
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-1900000000-429349a4645b8e438be7
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  67.0542500 156.4765 67.054886 0.7308 38.60 0.2786 28 f{C5H7}/0.35ppm,p-C4H11N1O2
  71.0604068 42.4913 71.061020 1.8013 14.14 -0.0415 26 ?
  72.0444173 146.5270 72.045024 1.0133 47.92 0.1490 29 f{C3H6N1O1}/0.38ppm,p-C6H12O1
  85.0760808 71.7125 85.076560 1.5516 16.62 0.4725 29 ?
  86.0600499 136.6760 86.060517 1.7197 45.69 0.1807 29 f{C4H8N1O1}/0.11ppm,p-C5H10O1
  86.0794340 39.9478 86.079900 2.0214 12.66 0.0246 25 ?
  87.0917159 170.7088 87.092169 1.0334 25.81 0.4225 29 ?
  88.0950027 113.7869 88.095442 1.8276 21.17 0.2674 29 ?
  89.0710335 39.1720 89.071459 2.2229 11.76 0.2599 24 ?
  95.0856591 46.5749 95.086019 1.6827 10.12 0.5672 26 f{C7H11}/1.39ppm,p-C2H7N1O2
  109.1012002 481.6706 109.101437 0.5041 92.08 0.3462 29 f{C8H13}/0.21ppm,p-C1H5N1O2
  111.0917441 97.2987 111.091960 1.9443 14.49 0.2705 29 ?
  112.0393272 197.9100 112.039532 1.1246 63.18 0.0592 29 f{C5H6N1O2}/0.20ppm,p-C4H12
  112.0757042 251.8499 112.075909 0.8030 32.61 0.4902 29 f{C6H10N1O1}/0.12ppm,p-C3H8O1
  112.0950444 178.8291 112.095249 1.2846 29.05 0.2540 29 ?
  119.0856735 56.1281 119.085795 2.0993 15.34 0.6759 28 f{C9H11}/1.23ppm,p-H7N1O2
  126.1025966 201.2339 126.102623 1.0864 46.74 0.2527 29 ?
  127.0866791 111.1983 127.086692 1.8885 24.79 0.2094 29 ?
  129.0660736 40.3580 129.066057 2.3476 10.44 0.0738 27 ?
  130.0499070 159.8598 130.049876 1.0611 56.21 -0.1166 29 ?
  137.0961914 174.4859 137.096098 1.2035 50.68 0.8767 29 f{C9H13O1}/0.73ppm,p-H5N1O1
  142.0977116 99.9200 142.097614 2.3998 25.64 -0.1178 29 f{C8H14O2}/-7.88ppm,p-C1H4N1
  144.1133456 53.5719 144.113247 2.1650 19.09 0.3327 29 f{C8H16O2}/-7.88ppm,p-C1H2N1
  154.0977974 44.7614 154.097693 1.9533 12.52 -0.3315 23 f{C9H14O2}/-6.71ppm,p-H4N1
  154.1228272 562.7298 154.122722 1.3236 183.46 0.9475 29 f{C9H16N1O1}/1.21ppm,p-H2O1
  154.1342507 130.7242 154.134146 0.9991 28.63 0.1844 29 ?
  155.0818688 104.0824 155.081763 2.1666 36.81 0.0293 29 ?
  155.1068707 144.0075 155.106765 1.9728 33.13 0.4518 29 f{C9H15O2}/1.38ppm,p-H3N1
  155.1182896 79.9578 155.118184 2.4111 25.67 0.5672 29 ?
  172.0959308 50.0906 172.095814 2.8589 21.34 -0.3132 29 ?
  172.1084649 472.7341 172.108349 3.0562 100.39 0.4072 29 ?
  172.1322345 669.0967 172.132118 1.8126 178.68 1.0000 27 f{C9H18N1O2}/-5.64ppm,p
  172.1452216 102.3186 172.145105 1.6207 38.40 -0.1193 21 ?
  172.1644309 999.0000 172.164314 1.4231 11.52 0.4603 29 ?
  173.1172529 413.2497 173.117136 0.5719 92.59 0.2497 29 ?
PK$NUM_PEAK: 35
PK$PEAK: m/z int. rel.int.
  67.054250 156.48 156
  71.060407 42.49 42
  72.044417 146.53 146
  85.076081 71.71 71
  86.060050 136.68 136
  86.079434 39.95 39
  87.091716 170.71 170
  88.095003 113.79 113
  89.071034 39.17 39
  95.085659 46.57 46
  109.101200 481.67 481
  111.091744 97.30 97
  112.039327 197.91 197
  112.075704 251.85 251
  112.095044 178.83 178
  119.085674 56.13 56
  126.102597 201.23 201
  127.086679 111.20 111
  129.066074 40.36 40
  130.049907 159.86 159
  137.096191 174.49 174
  142.097712 99.92 99
  144.113346 53.57 53
  154.097797 44.76 44
  154.122827 562.73 562
  154.134251 130.72 130
  155.081869 104.08 104
  155.106871 144.01 144
  155.118290 79.96 79
  172.095931 50.09 50
  172.108465 472.73 472
  172.132234 669.10 669
  172.145222 102.32 102
  172.164431 999.00 999
  173.117253 413.25 413
//
